Related Experiment Video
Updated: Nov 4, 2025

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
Immune-bacteriophage interactions in inflammatory bowel diseases
Lasha Gogokhia1, June L Round2
1Department of Pathology, University of Utah School of Medicine, Division of Microbiology and Immunology, UT 84112, United States; Department of Internal Medicine, St. Mary's Hospital, Waterbury, CT 06706, United States.
Bacteriophages, viruses infecting bacteria, may influence inflammatory bowel disease (IBD) by interacting with the immune system. This interaction offers potential new avenues for IBD diagnosis and treatment.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), has complex origins.
- The gut microbiome, comprising bacteria, fungi, and viruses, plays a role in IBD pathogenesis.
- Bacteriophages, viruses that infect bacteria, are abundant in the human gut.
Purpose of the Study:
- To review current research on bacteriophage-mammalian immune cell interactions.
- To explore the potential of bacteriophages in influencing IBD beyond their role in bacterial infection.
- To identify novel diagnostic and therapeutic strategies for IBD.
Main Methods:
- Literature review of recent studies on bacteriophages and the immune system.
- Analysis of research investigating bacteriophage-mammalian interactions in the context of IBD.
- Synthesis of findings related to viral particles impacting host immunity.
Main Results:
- Bacteriophages can interact with mammalian immune cells.
- These interactions may influence inflammatory processes relevant to IBD.
- The role of bacteriophages extends beyond bacterial pathogen control.
Conclusions:
- Bacteriophage-mammalian immune cell interactions represent a novel factor in IBD.
- Understanding these interactions could lead to new diagnostic tools for IBD.
- Targeting bacteriophage-immune pathways may offer innovative therapeutic approaches for IBD.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...